Contribution of antiangiogenic agents to the risk of medication-related osteonecrosis of the jaw in combination with antiresorptive agents: Preliminary results in a comparative prospective report of 59 oncologic cases-Reference-Cited by-同舟云学术

Contribution of antiangiogenic agents to the risk of medication-related osteonecrosis of the jaw in combination with antiresorptive agents: Preliminary results in a comparative prospective report of 59 oncologic cases

Published:2022 Issue:5 Volume:12 Page:564
ISSN:2231-0762
Container-title:Journal of International Society of Preventive and Community Dentistry
language:en
Short-container-title:J Int Soc Prevent Communit Dent

Author:

Dequanter Didier,Yanni Antoine,Bouland Cyril,Monteiro Raquel,Rodriguez Alexandra,Loeb Isabelle,Javadian Rokneddine

Publisher

Medknow

Subject

General Dentistry

Reference24 articles.

1. Marx RE Pamidronate (aredia) and zoledronate (zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg 2003;61:1115-7.

2. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update;Ruggiero;J Oral Maxillofac Surg,2014

3. Rollason V, Laverrière A, MacDonald LC, Walsh T, Tramèr MR, Vogt-Ferrier NB Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ). Cochrane Database Syst Rev 2016;2:CD008455.

4. Case reports of medication-related osteonecrosis of the jaw (MRONJ) treated with uncultured stromal vascular fraction and L-PRF;Bouland;J Stomatol Oral Maxillofac Surg,2021

5. McLeod NM, Brennan PA, Ruggiero SL Bisphosphonate osteonecrosis of the jaw: A historical and contemporary review. Surgeon 2012;10:36-42.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Performance of Implant-Supported Prostheses in the Rehabilitation of Patients Previously Treated for Medication-Related Osteonecrosis of the Jaws (MRONJ): A Systematic Review;Cureus;2024-06-04